Medtox Scientific (MTOX)

Yes, you're correct. In the most recent quarter, it was $215,000. Last year, it was $1,962,000. Typically, it has been running right around $2 million per year, the Contract Manufacturing -- $1.8 million, $1.9 million, right around there.

8

Steve Crowley - Craig-Hallum Capital - Analyst

Do you think it will tail off from the $200,000 that it is now, since you've experienced a big part of the downtick? Or is it going to bounce up and then tail off?

Dick Braun, MEDTOX. - Chairman, President & CEO

We can't predict that. It will probably move around from quarter to quarter, based upon the clients' requirements. Because the clients that we do this for, and they are only a small number, they need this as a component in their product. They sort of have a lifecycle to these products, so we have to work with them to ensure that they are provided with the component they need. It gets quite complex, in terms of the agreements and lifetime buys and so forth. So I guess the only somewhat predictable thing is that, and I can say it with some degree of certainty, that over that time frame, we won't be doing it anymore. But in the meantime, it will move around from quarter to quarter.

Steve Crowley - Craig-Hallum Capital - Analyst

I apologize to have to ask this, but the timeframe you said you were going to wind it down -- was it in fact 18 months?

Dick Braun, MEDTOX. - Chairman, President & CEO

18 to 24 months.

Steve Crowley - Craig-Hallum Capital - Analyst

So it looks like you had a pretty sizable challenge in this most recent quarter, but kind of walked through it just fine.

Dick Braun, MEDTOX. - Chairman, President & CEO

Correct.

Sure, Brent, this is Kevin Wiersma. Volume from existing clients in the quarter was up just slightly from the fourth quarter of last year, and overall for the year it was up slightly as well. But that base seems to be fairly stable.

6

Brent Miley - Rutabaga Capital - Analyst

Okay. And general volumes for the year, sort of including the new clients, would have been up -- you mentioned pricing was pretty stable. So can I just take the revenue number and assume that you basically did grow units by approximately... ?